The DNA demethylating agent 5-aza-2′-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Pierre Fenaux, Ghulam J. Mufti, Eva Hellström‐Lindberg et al. · The Lancet Oncology · 2009 · 2.6K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Cellular differentiation, cytidine analogs and DNA methylation

Peter A. Jones, Shirley M. Taylor · Cell · 1980 · 1.9K citations

Life Sciences, Cell Biology, Molecular Biology +16

Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B

Lewis R. Silverman, Erin P. Demakos, Bercedis L. Peterson et al. · Journal of Clinical Oncology · 2002 · 1.8K citations

Medicine, Internal Medicine, Pharmacotherapy +16

Decitabine improves patient outcomes in myelodysplastic syndromes

Hagop M. Kantarjian, Jean‐Pierre J. Issa, C Rosenfeld et al. · Cancer · 2006 · 1.5K citations

Medicine, Hematology, Pharmacology +14

The DNA sequence of the human X chromosome

Mark T. Ross, Darren Grafham, Alison J. Coffey et al. · Nature · 2005 · 1.2K citations · Full text

Life Sciences, Genetics, Molecular Genetics +14